BioForce targets NIH (National Institutes of Health) grant at NanoArray technology:
This article was originally published in Clinica
Executive Summary
BioForce Nanosciences will use a $500,000 grant from the US National Institutes of Health to develop its Nanoarrayer molecular deposition tool, a technology for creating miniaturised biological tests. The technology, which places thousands of molecules at defined locations on a single microarray spot, allows for the development of a broad spectrum of ultra-sensitive, ultra-miniaturised biological tests, such as blood screens and the detection of pathogenic material, says the Ames, Iowa firm.